medical research statistics


 

 Biomedical Research
 

What is alpha-1 antitrypsin defciency?

Alpha-1 antitrypsin deficiency (AATD) is an inherited condition that causes low levels of, or no, alpha-1 antitrypsin (AAT) in the blood. AATD occurs in approximately 1 in 2,500 individuals. This condition is found in all ethnic groups; however, it occurs most often in whites of European ancestry.

Alpha-1 antitrypsin (AAT) is a protein that is made in the liver. The liver releases this protein into the bloodstream. AAT protects the lungs so they can work normally. Without enough AAT, the lungs can be damaged, and this damage may make breathing difficult.

Everyone has two copies of the gene for AAT and receives one copy of the gene from each parent. Most people have two normal copies of the alpha-1 antitrypsin gene. Individuals with AATD have one normal copy and one damaged copy, or they have two damaged copies. Most individuals who have one normal gene can produce enough alpha-1 antitripsin to live healthy lives, especially if they do not smoke.

People who have two damaged copies of the gene are not able to produce enough alpha- 1 antitrypsin, which leads them to have more severe symptoms.

 

Medical Research

 

 

 

Facts about Animal Research

Understanding Animal Research in Medicine

Medical Discoveries and Animal Research

National Institute of Health's Protocols Animals Research

Animal Research Publications

Patient Studies

Grants for Medical Research

 Health Articles:

Chiropractor
Dentist
Dermatologist
Eye Doctor
Gynecologist
Massage Therapist
Ophthalamologist
Optometrist
Orthopedic Surgeon
Physical Therapist
Plastic Surgeon
Rheumatologist
Skin Doctor
Speech Pathologist
Travel Nurse
Podiatrist
Neurologist
Psychiatrist
Psychologist
Ear Nose and Throat
Infectious Disease
Sexual Health
Drug Rehab


Autoimmune LymphoProliferative (ALPS)
Autosomal Dominant Polycystic
Breast Cancer
Charcot Marie Tooth
Colon Cancer
Cri Du Chat
Cystic Fibrosis
Dercum
Down syndrome
Duane Syndrome
Duchenne Muscular Dystrophy
Leiden Thrombophilia
Hereditary Hemochromatosis
Progeria
Prostate Cancer
Retinitis Pigmentosa
Severe Combined Immunofeficiency
Sickle Cell Disease
Skin Cancer